Management ChangeApr 22, 2026, 06:07 AM
DocGo Director Klasko to Depart; Michael Burdiek Named Chair
AI Summary
Dr. Stephen K. Klasko will step down from DocGo Inc.'s Board of Directors and committee positions, effective June 16, 2026, to pursue a new significant healthcare leadership role. His departure is not due to any disagreement with the company. Concurrently, Michael Burdiek, a long-serving independent director, has been appointed as the new independent Chair of the Board, effective the same date. Additionally, Jim Travers was appointed to the Audit and Compliance Committee and the Nominating and Corporate Governance Committee.
Key Highlights
- Dr. Stephen K. Klasko will resign from DocGo's Board of Directors.
- His departure is effective June 16, 2026, due to a new leadership role.
- Michael Burdiek, an independent director, appointed as the new independent Chair of the Board.
- Jim Travers appointed to the Audit and Compliance Committee and Nominating and Corporate Governance Committee.
- Dr. Klasko's decision was not due to any disagreement with the company.